30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Carlos Alban

Track

Insider profile

Currently holds a position at Abbvie Inc

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
15 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Vice Chairman, Chief Commercial Officer Abbvie Inc Dec. 13, 2018 -
Executive Vice President - Commercial Operations Abbvie Inc Jan. 2, 2013 - Dec. 13, 2018
Senior Vice President - Proprietary Pharmaceutical Products, Global Commercial Operations Abbott Laboratories Jan. 1, 2011 - Jan. 1, 2012
Carlos Alban's trades of Abbvie Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-03-02 2018-03-01
US Abbvie Inc (ABBV)
S Sale
72,844 -36.5%
244.43
US$4,909,300 		72,844 -36.5% 244.43 US$4,909,300
2018-03-02 2018-03-01
US Abbvie Inc (ABBV)
S Sale
33,574 +17.3%
213.37
US$2,728,210 		33,574 +17.3% 213.37 US$2,728,210
2018-03-02 2018-03-01
US Abbvie Inc (ABBV)
S Sale
19,295 +14.6%
21.96
US$3,463,759 		19,295 +14.6% 21.96 US$3,463,759
2018-03-02 2018-02-28
US Abbvie Inc (ABBV)
S Sale
2,579 -1.9%
117.85
US$303,928 		2,579 -1.9% 117.85 US$303,928
2017-06-15 2017-06-14
US Abbvie Inc (ABBV)
S Sale
45,800 -28.5%
70.00
US$3,206,000 		45,800 -28.5% 70.00 US$3,206,000
2017-05-08 2017-05-04
US Abbvie Inc (ABBV)
S Sale
43,000 -27.3%
67.00
US$2,881,000 		43,000 -27.3% 67.00 US$2,881,000
2016-05-12 2016-05-10
US Abbvie Inc (ABBV)
S Sale
47,438 -24.1%
63.52
US$3,013,262 		47,438 -24.1% 63.52 US$3,013,262
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
600 -0.3%
50.09
US$30,056 		600 -0.3% 50.09 US$30,056
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
400 -0.2%
50.09
US$20,036 		400 -0.2% 50.09 US$20,036
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
282 -0.1%
50.09
US$14,125 		282 -0.1% 50.09 US$14,125
2014-03-04 2014-03-03
US Abbvie Inc (ABBV)
S Sale
1,600 -0.8%
50.09
US$80,138 		1,600 -0.8% 50.09 US$80,138
2013-05-03 2013-05-01
US Abbvie Inc (ABBV)
S Sale
27,664 -13.6%
45.68
US$1,263,683 		27,664 -13.6% 45.68 US$1,263,683
2013-05-03 2013-05-01
US Abbvie Inc (ABBV)
S Sale
30,550 -13.0%
45.68
US$1,395,426 		30,550 -13.0% 45.68 US$1,395,426
2013-05-03 2013-05-01
US Abbvie Inc (ABBV)
S Sale
27,320 -10.4%
45.66
US$1,247,562 		27,320 -10.4% 45.66 US$1,247,562
2013-05-03 2013-05-01
US Abbvie Inc (ABBV)
S Sale
28,122 -9.7%
45.68
US$1,284,717 		28,122 -9.7% 45.68 US$1,284,717